Back to top

Canaccord Genuity Reaffirms Their Buy Rating on Tyra Bioscience (TYRA)

In a report released today, John Newman from Canaccord Genuity maintained a Buy rating on Tyra Bioscience, with a price target of $50.00. According...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Tyra Biosciences, Inc. (TYRA)